SEC Form D private-offering filing

Iambic Therapeutics, Inc.

Name: Iambic Therapeutics, Inc. - new SEC Form D private-offering filing, San Diego, CA
Published: 2025-11-21

A new SEC Form D private-offering notice from San Diego, CA, a $124,999,970 filer-stated offering target in Biotech. The source filing is one click away.

Iambic Therapeutics, Inc. site↗ Verified via SEC Form D

AI-driven clinical-stage biotechnology company developing novel medicines using machine learning drug discovery platforms, with an oncology-focused pipeline.

Filed 2025-11-21Filed to raise $124,999,970First money in 2025-11-06Raised so far $99,269,270HQ (as filed) San Diego, CASector Biotech ✓Stage (inferred) LateCall status Call-ready

Source linked the Form D on EDGAR↗Website verified iambic.ai↗Named in the filing 12 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.